Delivery Order SPE2DB22D2211-SPE2DB25FSDVL
- Not listed
- The Defense Logistics Agency awarded a $3,073.28 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,269.13 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,418.22 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.18 for 100 capsules of Vyvanse 50 mg on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a purchase order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999.99 billion ceiling...
- The Defense Logistics Agency awarded a $3,140.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for the supply of Vyvanse 40 mg capsules (100-count packages) valued at $3,908.42. This non-set-aside, competitively awarded delivery order represents a firm fixed-price contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, PA. The award is funded by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) valued at $2,589.86 under a firm fixed-price arrangement. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $1,138.69 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, with an ultimate completion date of August 21, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $17.4K delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (40mg) under a firm fixed-price contract. The delivery order, issued on August 5, 2025, represents a non-competitive, competitively awarded transaction with a completion deadline of August 6, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery....
- The Defense Logistics Agency awarded a delivery order valued at $9,138.78 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg on August 8, 2025, with completion targeted for August 11, 2025. This is a firm fixed price, non-set-aside contract under a child delivery order arrangement. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDVLDelivery Order
The Defense Logistics Agency awarded a $2,085.82 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on August 28, 2025, with completion expected by August 29, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling diverse pharmaceutical requirements through its DLA contract portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The performance location for this delivery order is the company's corporate office in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/28/25 |